Clinical Trials Logo

Tendon Injuries clinical trials

View clinical trials related to Tendon Injuries.

Filter by:

NCT ID: NCT02532595 Completed - Clinical trials for Achilles Tendon Injury

TDN, Manual Therapy and Exercise For the Management of Achilles Tendinopathy

Start date: May 2015
Phase: N/A
Study type: Interventional

Conflicting evidence exists regarding the recommendations from the Orthopaedic section of the American Physical Therapy Association for treatment of Achilles tendinitis. Trigger point dry needling is effective in reducing pain in several body regions, but no published (TDN) studies are found reporting the effect on Achilles tendinopathy. The purpose of this study is to investigate whether a treatment program performed including TDN, manual therapy and exercise will result in a significant improvement in pain, strength and function compared to a treatment program including manual therapy and exercise for Achilles tendinopathy. Subjects with Achilles tendinopathy that receive treatment including TDN, manual therapy and exercise will demonstrate a significant improvement in pain, strength and functional outcomes compared to the group that receives manual therapy and exercise.

NCT ID: NCT02461680 Terminated - Clinical trials for Flexor Tendon Injury

Treatment for Partial Lesions of the Fingers Flexor Tendons : Tangential Resection or Direct Suture

FLEXOR
Start date: February 2016
Phase: N/A
Study type: Interventional

Flexors tendon injuries are frequent and serious with a potential of definitive functional aftereffects. In the case of partial injury, the treatment is debated. There are 2 techniques of possible repair, the direct suture and the tangential resection. The investigators have already demonstrated that this last technique was favorable for injuries going to 50 %. In the case of partial section between 50 and 75 %, the investigators think that the technique of tangential resection compared with the direct suture would not increase the risks of secondary breaks, would authorize even an immediate mobilization and would decrease the secondary complications. The main objective is to highlight that the tangential resection is not lower than the classic technique on the clinical plan The secondary objectives are to highlight the non-inferiority of the tangential technique in clinical terms (pains, dexterity, complications), radiologics (MRI, ultrasound) and functional (function, go back to leisures and professional activities)

NCT ID: NCT02361814 Terminated - Clinical trials for Flexor Tendon Injury

The Effect of Human Amniotic Membrane Allograft on Functional Recovery After Flexor Tendon Repair

Start date: March 2015
Phase: N/A
Study type: Interventional

The objective of this pilot study is to gain observational insight into potential preventive features of amniotic membrane transplantation in the adhesion formation after flexor tendon repair.

NCT ID: NCT02340273 Terminated - Clinical trials for Musculoskeletal Pain

Long Duration Therapeutic Ultrasound on Tendon Injuries

Start date: December 2014
Phase: N/A
Study type: Interventional

Human clinical trial to measure the effect of long duration therapeutic ultrasound on tendon injuries. The hypothesis is that use of long duration ultrasound will relieve pain, increase tendon strength, and improve quality of life for patients with tendon injury.

NCT ID: NCT02309307 Completed - Tendinopathy Clinical Trials

Tissue Repair Device (VergenixTM STR) in Patients With Epicondylitis (Tennis Elbow)

CP-STR-01
Start date: January 11, 2015
Phase: N/A
Study type: Interventional

The VergenixTM STR device is intended for the repair of non ruptured tendon injuries (Tendinopathy).

NCT ID: NCT02298023 Completed - Rotator Cuff Tear Clinical Trials

Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)

Start date: September 2014
Phase: Phase 2
Study type: Interventional

Main purpose of this study is to evaluate efficacy of allogenic adipose-derived mesenchymal stem cells in treatment of tendon injury. ALLO-ASC will be administrated to the patients with supraspinatus partial thickness tear by ultrasonographic guided injection.

NCT ID: NCT02231190 Completed - Tendon Injuries Clinical Trials

GSK1278863 Effects on Eccentric Exercise-Induced Muscle Damage

Start date: January 15, 2015
Phase: Phase 1
Study type: Interventional

As per non-clinical studies, prolyl hydroxylase inhibitor GSK1278863 can protect muscle from unaccustomed exercise induced muscle damage and enhance functional muscle repair. This study is designed to investigate arm function, pain and other pharmacodynamic (PD) markers after unaccustomed maximal eccentric exercise with concurrent administration of GSK1278863 or placebo. Primary objective of the study is to evaluate the protective effects of GSK1278863 on eccentric exercise induced muscle injury. Subjects will be randomized in a 1:1 ratio (1 subject on GSK1278863 for every 1 subject on placebo). Each subject will be given five oral doses of GSK1278863/placebo in total. The first dose will be administered immediately after completion of eccentric exercise and then 4, 8, 24, and 48 hours later. Subjects will be housed till day 4 in unit and will return for a follow-up visit 7-10 days after discharge. After enrolment of approximately 30 subjects, enrolment will be paused and planned interim analysis will be performed to decide whether to terminate enrolment/study, continue dosing or to reduce the dose to 5 milligrams (mg).

NCT ID: NCT02014662 Completed - Tendon Injuries Clinical Trials

A Methodology Study to Assess Muscle Damage After Eccentric Exercise

Start date: January 14, 2014
Phase: Phase 1
Study type: Interventional

An isolated bout of unaccustomed maximal eccentric exercise is associated with muscle force loss for 2-4 days, mild reversible muscle tenderness, and ultra-structural damage to the muscle fibers, elevation of muscle proteins in serum, and a detriment in range of motion. This single center, pilot study is designed to optimize conditions for the robust measurement of functional deficits after muscle damage and to identify markers of repair over 22 days to inform future intervention studies. The primary measure will be limb force (assessed electronically from the ergometer), previous studies have demonstrated that functional measures return fairly rapidly, usually between 2-4 days. Additionally, several biomarkers of muscle function will be measured over 22 days, as well as changes in protein synthesis in biopsy samples Deuterium-labelled water (D2O) will be consumed by all study participants from Day-3 through Day 22 to aid in quantifying newly synthesized proteins.

NCT ID: NCT01856140 Completed - Clinical trials for Lateral Epicondylitis

Treatment of Tendon Injury Using Mesenchymal Stem Cells

ALLO-ASC
Start date: May 2013
Phase: Early Phase 1
Study type: Interventional

Main purpose of this study is to evaluate efficacy and safety of allogenic adipose-derived mesenchymal stem cells(ALLO-ASC) in treatment of tendon injury. ALLO-ASC will be administrated to the patients with lateral epicondylitis by ultrasonographic guided injection.

NCT ID: NCT01726855 Completed - Tendon Injuries Clinical Trials

Prevention of Adhesions Following Flexor Tendon Injury Within Zone II With Vascularized Finger Dorsal Fascial Flap

Start date: January 2010
Phase:
Study type: Observational

The purpose of this study was to report a new method of flexor tendon repair in zone II with combined standard modified Kessler technique and vascularized finger dorsal fascial flap pedicled with dorsal cutaneous branch of proper digital artery ,which is transported to finger volar for placement of a mechanical barrier between flexor digitorum superficialis /profundus tendons. The function outcomes of 14 patients (Group A) with flexor tendon repair in zone II with this new technique were compared with those of 32 patients (Group B) with flexor tendon repair in zone II with standard modified Kessler technique. This new technique may prevent serious adhesions between flexor digitorum superficialis /profundus tendons.